GBA1 and Parkinson disease: Collectively, these studies indicate that LRRK2 and GBA influence each other in the regulation of lysosomal function and that LRRK2 kinase inhibitor may be a potential treatment strategy to correct defects in lysosome and cytokine response in not only LRRK2-PD but also GBA-PD or perhaps even iPD.